Cargando…

FEV(1) is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease

PURPOSE: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. Impaired lung function is associated with heightened risk for death, cardiovascular events, and COPD exacerbations. However, it is unclear if forced expiratory volume in one second (FEV(1)) and for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bikov, Andras, Lange, Peter, Anderson, Julie A, Brook, Robert D, Calverley, Peter M A, Celli, Bartolome R, Cowans, Nicholas J, Crim, Courtney, Dixon, Ian J, Martinez, Fernando J, Newby, David E, Yates, Julie C, Vestbo, Jørgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247606/ https://www.ncbi.nlm.nih.gov/pubmed/32547001 http://dx.doi.org/10.2147/COPD.S242809

Ejemplares similares

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019)

Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial
por: Byrd, James Brian, et al.
Publicado: (2018)

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
por: Brook, Robert D, et al.
Publicado: (2017)

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial
por: Brigham, Emily P., et al.
Publicado: (2021)

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease
por: Adamson, Philip D., et al.
Publicado: (2018)

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2022)

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review
por: Celli, Bartolome R., et al.
Publicado: (2021)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

FEV(1) Is a Better Predictor of Mortality than FVC: The PLATINO Cohort Study
por: Menezes, Ana Maria B., et al.
Publicado: (2014)

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change
por: Jones, Paul W, et al.
Publicado: (2011)

Forced Expiratory Volume in 6 s (FEV(6)) and FEV(1)/FEV(6) Values as a Viable Alternative for Forced Vital Capacity (FVC) and FEV(1)/FVC Values During Pregnancy in South East Nigeria: A Preliminary Study
por: Nwagha, U, et al.
Publicado: (2014)

A mathematical reason for FEV1/FVC dependence on age
por: Gólczewski, Tomasz, et al.
Publicado: (2012)

Association between 25-hydroxy vitamin D and lung function (FEV1, FVC, FEV1/FVC) in children and adults with asthma: A systematic review
por: Abi-Ayad, Meryem, et al.
Publicado: (2023)

Comparison between reference values for FVC, FEV(1), and FEV(1)/FVC ratio in White adults in Brazil and those suggested by the Global Lung Function Initiative 2012
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2014)

Effect of Different Positions on FVC and FEV(1) Measurements of Asthmatic Patients
por: Melam, Ganeswara Rao, et al.
Publicado: (2014)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

Responses of FEV(6), FVC, and FET to inhaled bronchodilator in the adult general population
por: Kainu, Annette, et al.
Publicado: (2009)

FEV(1) and FVC and systemic inflammation in a spinal cord injury cohort
por: Hart, Jaime E., et al.
Publicado: (2017)

Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD
por: Fawzy, Ashraf, et al.
Publicado: (2019)

Reply to Fisk and Wilkinson: Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease
por: Crim, Courtney, et al.
Publicado: (2020)

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
por: Celli, Bartolome, et al.
Publicado: (2021)

Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
por: Agustí, Alvar, et al.
Publicado: (2012)

Characterisation of COPD heterogeneity in the ECLIPSE cohort
por: Agusti, Alvar, et al.
Publicado: (2010)

Factors Associated with the Expression of ACE2 in Human Lung Tissue: Pathological Evidence from Patients with Normal FEV(1) and FEV(1)/FVC
por: Bao, Wuping, et al.
Publicado: (2021)

The ratio FEV(1)/FVC and its association to respiratory symptoms—A Swedish general population study
por: Torén, Kjell, et al.
Publicado: (2020)

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
por: Jenkins, Christine R, et al.
Publicado: (2009)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Rapid FEV(1)/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population
por: Choi, Kwang Yong, et al.
Publicado: (2022)

The severity of airways obstruction as a determinant of treatment response in COPD
por: Calverley, Peter MA, et al.
Publicado: (2006)

Basic and clinical immunology – 3028. Interaction of DNA methylation and genetic variants of IL13 is associated with FEV1/FVC and BHR
por: Patil, Veeresh K, et al.
Publicado: (2013)

Measuring slow vital capacity to detect airflow limitation in a woman with dyspnea and a preserved FEV(1)/FVC ratio
por: Berton, Danilo Cortozi, et al.
Publicado: (2019)

FEV(1) Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn
por: Crim, Courtney, et al.
Publicado: (2021)

Defining and grading an obstructive ventilatory defect (OVD): ‘FEV(1)/FVC lower limit of normal (LLN) vs. Z-score’ and ‘FEV(1) percentage predicted (%pred) vs. Z-score’
por: Kammoun, Rim, et al.
Publicado: (2018)

Measures of bronchodilator response of FEV(1), FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS Pilot Study
por: Torén, K, et al.
Publicado: (2017)

Airway Measurement for Airway Remodeling Defined by Post-Bronchodilator FEV1/FVC in Asthma: Investigation Using Inspiration-Expiration Computed Tomography
por: Chae, Eun Jin, et al.
Publicado: (2011)

BMI, waist circumference at 8 and 12 years of age and FVC and FEV(1) at 12 years of age; the PIAMA birth cohort study
por: Bekkers, Marga B, et al.
Publicado: (2015)

Effects of PM(2.5) and NO(2) on the 8-isoprostane and lung function indices of FVC and FEV(1) in students of Ahvaz city, Iran
por: Hashemzadeh, Bayram, et al.
Publicado: (2019)

Environmental and Occupational Short-Term Exposure to Airborne Particles and FEV(1) and FVC in Healthy Adults: A Systematic Review and Meta-Analysis
por: da Silveira Fleck, Alan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jsfnpd7c21v2a05pauhktr5r4o